INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 69 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,559,000 | +132.4% | 980,225 | +58.5% | 0.00% | – |
| Q3 2017 | $1,101,000 | +82.9% | 618,552 | +95.3% | 0.00% | – |
| Q2 2017 | $602,000 | -57.1% | 316,713 | -54.9% | 0.00% | – |
| Q1 2017 | $1,403,000 | -44.1% | 701,655 | +70.6% | 0.00% | – |
| Q4 2016 | $2,508,000 | -57.1% | 411,222 | -33.3% | 0.00% | – |
| Q3 2016 | $5,846,000 | +32.1% | 616,656 | +3.6% | 0.00% | – |
| Q2 2016 | $4,427,000 | +13.4% | 595,073 | +12.8% | 0.00% | – |
| Q1 2016 | $3,903,000 | -25.9% | 527,516 | +13.5% | 0.00% | – |
| Q4 2015 | $5,266,000 | -31.4% | 464,735 | -43.1% | 0.00% | – |
| Q3 2015 | $7,676,000 | +4552.1% | 816,720 | +2323.5% | 0.00% | – |
| Q2 2015 | $165,000 | – | 33,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,627,790 | $5,256,000 | 7.39% |
| FT Options LLC | 477,763 | $956,000 | 1.26% |
| Sio Capital Management, LLC | 726,900 | $1,454,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 852,022 | $1,704,000 | 0.43% |
| DAFNA Capital Management LLC | 237,135 | $474,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 401,764 | $804,000 | 0.16% |
| DLD Asset Management, LP | 439,500 | $870,000 | 0.14% |
| Minerva Advisors LLC | 64,759 | $126,000 | 0.07% |
| SHEPHERD KAPLAN KROCHUK, LLC | 36,000 | $72,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 96,435 | $193,000 | 0.04% |